Kezar Life Sciences
KZR
$0.86
Share price
0.32%
Change (1 day)
-67.15%
Change (1 year)
Categories
Kezar Life Sciences (KZR) - P/B ratio
P/B ratio as of May 2024 : 0.3317
According to Kezar Life Sciences's latest financial reports the company has a price-to-book ratio of 0.3317.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Kezar Life Sciences - P/B ratio (from 2018 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.3672 | -79.42% |
| 2022-12-31 | 1.78 | -62.69% |
| 2021-12-31 | 4.78 | 178.54% |
| 2020-12-31 | 1.72 | 73.93% |
| 2019-12-31 | 0.9869 | -76.2% |
| 2018-12-31 | 4.15 | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | 763.44% | 🇺🇸 USA |